A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Level 5 - mechanism / opinion, no new human data
Bench research / molecular mechanism study with no human or clinical data.
OpenAlex W2045435533 · doi:10.1126/science.1225829
What was done
The authors investigated the molecular mechanism of target DNA cleavage by the CRISPR-associated Cas9 endonuclease in bacterial adaptive immunity. They analyzed how mature crRNA base-paired to trans-activating crRNA (tracrRNA) directs Cas9, mapped the cleavage roles of the HNH and RuvC-like nuclease domains to the complementary and noncomplementary DNA strands, and engineered a dual-tracrRNA:crRNA single-molecule RNA chimera to test sequence-specific target DNA cleavage.
What was found
The crRNA:tracrRNA dual-RNA structure directs Cas9 to introduce double-stranded breaks in target DNA. Cas9's HNH domain cleaves the complementary DNA strand, whereas its RuvC-like domain cleaves the noncomplementary strand at sites matching the crRNA guide sequence. An engineered single-guide RNA chimera successfully programmed Cas9 to introduce site-specific double-stranded DNA breaks. The abstract describes biochemical cleavage mechanisms and strand specificities but contains no numerical metrics.
Why it matters
This study establishes that Cas9 functions as a dual-RNA-guided DNA endonuclease and shows that an engineered single-guide RNA chimera can direct site-specific DNA cleavage, laying the molecular foundation for RNA-programmable genome editing.
Limits
The abstract reports purely in vitro biochemical mechanisms without data on eukaryotic cell editing, in vivo efficacy, or organismal delivery. No quantitative metrics on cleavage kinetics, efficiency, off-target rates, or sample numbers are provided in the abstract text.
Cited by
- supports In 2012, Emmanuelle Charpentier and Jennifer Doudna published a paper in Science describing the CRISPR technology for rewriting DNA sequences.